By NATALYA ORTOLANO @NatOrtolanoJULY 1, 2020 An experimental new HIV treatment could, with just one dose, reduce the amount of virus in an infected person for up to six months. But experts aren’t convinced the advance will significantly change how we treat HIV anytime soon. A group of researchers from Gilead Sciences developed a new...
By Linda NordlingJun. 15, 2020 , 4:30 PM Science’s COVID-19 reporting is supported by the Pulitzer Center. CAPE TOWN, SOUTH AFRICA—Living with HIV or active tuberculosis (TB) increases a person’s likelihood of dying from COVID-19, preliminary data from South Africa show. However, the effect is small compared with other known risk factors such as old...
Scientists announced a potential breakthrough in the fight against HIV/AIDS Researchers at Paris’ Institut Pasteur found a way to destroy infected cells Currently HIV is treated with antiretroviral drugs which cannot remove the virus Researchers claim to have found a way to eliminate infected ‘reservoir’ cells Scientists have announced a potentially major breakthrough in the...
Novel study suggests HIV-1 still detectable in human liver macrophages unlikely to stay infectious after long-term antiretroviral therapy JOHNS HOPKINS MEDICINE In a proof-of-principle study, researchers at Johns Hopkins report that a certain liver immune cell called a macrophage contains only defective or inert HIV-1 copies, and aren’t likely to restart infection on their own...
